Associations of insulin resistance and type 2 diabetes to heart failure: Epidemiology, potential mechanisms, and clinical perspectives

被引：0

作者：

Ingelsson E. ^{[1
]}

机构：

[1] Department of Public Health and Caring Sciences, Uppsala University, SE-751 85 Uppsala, Uppsala Science Park

来源：

Current Cardiovascular Risk Reports | 2008年 / 2卷 / 1期

关键词：

Heart Failure; Insulin Resistance; Metformin; Chronic Heart Failure; Heart Failure Patient;

D O I：

10.1007/s12170-008-0012-5

中图分类号：

学科分类号：

摘要：

Heart failure, a common condition in most industrialized nations, is disabling and deadly. Type 2 diabetes, recognized as a risk factor for incident heart failure more than three decades ago, consistently has been associated with a twofold to threefold increased risk of heart failure and type 2 diabetes often coexist, and several studies have shown that type 2 diabetes in heart failure patients is associated with markedly increased mortality. Insulin resistance recently was reported to be a predictor of heart failure incidence independent of established risk factors, including diabetes and obesity. This review summarizes the literature regarding the associations of insulin resistance and type 2 diabetes to heart failure, and it discusses potential mechanisms underlying these associations and clinical perspectives. © 2008 Current Medicine Group LLC.

引用

页码：60 / 65

页数：5

共 50 条

[1]

McMurray J.J., Pfeffer M.A., Heart failure, Lancet, 365, pp. 1877-1889, (2005)

[2]

Krentz A.J., Insulin resistance, Bmj, 313, pp. 1385-1389, (1996)

[3]

Kannel W.B., Hjortland M., Castelli W.P., Role of diabetes in congestive heart failure: the Framingham study, Am J Cardiol, 34, pp. 29-34, (1974)

[4]

Chen Y.T., Vaccarino V., Williams C.S., Et al., Risk factors for heart failure in the elderly: a prospective community-based study, Am J Med, 106, pp. 605-612, (1999)

[5]

Gottdiener J.S., Arnold A.M., Aurigemma G.P., Et al., Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study, J Am Coll Cardiol, 35, pp. 1628-1637, (2000)

[6]

He J., Ogden L.G., Bazzano L.A., Et al., Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study, Arch Intern Med, 161, pp. 996-1002, (2001)

[7]

Davis B.R., Piller L.B., Cutler J.A., Et al., Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, Circulation, 113, pp. 2201-2210, (2006)

[8]

Nichols G.A., Gullion C.M., Koro C.E., Et al., The incidence of congestive heart failure in type 2 diabetes: an update, Diabetes Care, 27, pp. 1879-1884, (2004)

[9]

Vaur L., Gueret P., Lievre M., Et al., Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study, Diabetes Care, 26, pp. 855-860, (2003)

[10]

Gustafsson I., Brendorp B., Seibaek M., Et al., Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure, J Am Coll Cardiol, 43, pp. 771-777, (2004)

← 1 2 3 4 5 →